| Trade Names: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N03AX18 |
Pharmacology
| Primary Target | |
|---|---|
| Nav1.7 |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Epilepsy; Seizures | Phase 2 | ClinicalTrials |
| Epilepsies, Partial | Phase 3 | ClinicalTrials |
| Neuralgia | Phase 2 | ClinicalTrials |
| Epilepsy | Phase 3 | ClinicalTrials |
| Epilepsy | Phase 2/Phase 3 | ClinicalTrials |
| Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Peripheral Nervous System Diseases; Small Fiber Neuropathy | Phase 3 | ClinicalTrials |
| Necrosis; Osteoarthritis | Phase 2 | ClinicalTrials |
| Epilepsy | Phase 3 | ClinicalTrials |
| Acute Kidney Injury; Renal Insufficiency | Phase 4 | ClinicalTrials |
| Epilepsy | Phase 1 | ClinicalTrials |
| Amyotrophic Lateral Sclerosis; Motor Neuron Disease; Sclerosis | Phase 1/Phase 2 | ClinicalTrials |
| Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Epilepsies, Partial; Seizures | Phase 2 | ClinicalTrials |
| Epilepsy | Phase 3 | ClinicalTrials |
| Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Seizures | Phase 4 | ClinicalTrials |
| Epilepsy; Epileptic Syndromes; Seizures | Phase 2 | ClinicalTrials |
| Epilepsies, Partial; Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Epilepsies, Partial; Epilepsy | Phase 4 | ClinicalTrials |
| Diabetic Neuropathies; Neuralgia; Peripheral Nervous System Diseases | Phase 2 | ClinicalTrials |
| Epilepsy; Seizures | Phase 2 | ClinicalTrials |
| Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Epilepsy | Phase 2 | ClinicalTrials |
| Seizures | Phase 3 | ClinicalTrials |
| Epilepsies, Partial; Epilepsy; Seizures | Phase 4 | ClinicalTrials |
| Diabetic Neuropathies; Peripheral Nervous System Diseases | Phase 2/Phase 3 | ClinicalTrials |
| Alcohol Drinking; Alcoholism; Disease | Phase 2 | ClinicalTrials |
| Migraine Disorders | Phase 2 | ClinicalTrials |
| Epilepsy | Phase 3 | ClinicalTrials |
| Diabetic Neuropathies; Pain | Phase 3 | ClinicalTrials |
| Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Epilepsies, Partial; Epilepsy | Phase 2 | ClinicalTrials |
| Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Epilepsy | Phase 4 | ClinicalTrials |
| Epilepsy | Phase 3 | ClinicalTrials |
| Epilepsies, Partial; Epilepsy | Phase 4 | ClinicalTrials |
| Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Epilepsy; Seizures | Phase 2 | ClinicalTrials |
| Epilepsies, Partial; Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Anxiety Disorders; Disease; Psychophysiologic Disorders; Schizophrenia; Somatoform Disorders | Phase 3 | ClinicalTrials |
| Status Epilepticus | Phase 3 | ClinicalTrials |
| Fibromyalgia; Myofascial Pain Syndromes; Signs and Symptoms; Syndrome | Phase 2 | ClinicalTrials |
| Epilepsies, Partial; Epilepsy; Seizures | Phase 3 | ClinicalTrials |
| Alcoholic Intoxication; Alcoholism | Phase 1 | ClinicalTrials |
| Glioma; Seizures | Phase 2 | ClinicalTrials |
| Osteoarthritis; Osteoarthritis, Knee | Phase 2 | ClinicalTrials |
| Diabetic Neuropathies; Pain | Phase 3 | ClinicalTrials |
| Epilepsy | Phase 4 | ClinicalTrials |
Side Effects from Label
Side Effects (PT)
Adverse Reactions
System Organ Classification (SOC)
CONTENTS